Biosensor Recession proof -heartstent biz

  • mardiindo sekuritas
  • Visitor
  • Visitor
11 years 10 months ago #9976 by mardiindo sekuritas
Replied by mardiindo sekuritas on topic Re:Biosensor Recession proof -heartstent biz
nomura target is more realistic, it really knows well for this company,1.9 is achieveable

Please Log in or Create an account to join the conversation.

  • goldie
  • Visitor
  • Visitor
11 years 10 months ago #9977 by goldie
oi mardiindo, why do you think Nomura knows this company well?
[hr]
[mardiindo sekuritas 17-07-2012]:

nomura target is more realistic, it really knows well for this company,1.9 is achieveable

Please Log in or Create an account to join the conversation.

  • Lim
  • Visitor
  • Visitor
11 years 10 months ago #9989 by Lim
Initiate at Buy with PO of S$1.55 (29% upside potential) by Bank of America

For full report, please email to tplim1975@gmail.com

Please Log in or Create an account to join the conversation.

  • BV
  • Visitor
  • Visitor
11 years 9 months ago #10101 by BV
Closed at $1.225 today, not sure whether to go in or not.

No dividend.....Clinical trials do take a long time to validate a product.

Good thing is this company is an innovative one, and doing something good for society in terms of the drug-eluting stents, etc.

Please Log in or Create an account to join the conversation.

  • BV
  • Visitor
  • Visitor
11 years 9 months ago #10150 by BV
ok, eluded me already at $1.25

Please Log in or Create an account to join the conversation.

More
11 years 9 months ago #10156 by Rock
Biosensor recession proof -heartstent biz without the incentive of dividend it may not be so attractive for investors to hold long term especially during this uncertain times.
Cordlife another recession proof medical stock looks atttractive for investors to hold long term with good dividend pay out. Cordlife is ready to power after recent bear purge out.

Please Log in or Create an account to join the conversation.

Time to create page: 0.211 seconds
Powered by Kunena Forum
 

We have 588 guests and no members online

rss_2 NextInsight - Latest News